Covid-19 vaccines can reduce the effects of the SARS-Cov-2 virus by letting the body develop an immune response to the virus. This immune response reduces the risk of developing serious illnesses when a person gets infected.
Many people who get infected by the virus can recover even if they stay at home. These people normally feel the same symptoms as the flu and may need to stay hydrated, get rest, and take medications.
People who have a severe case of the disease may need more than simple bed rest and hydration. They may require hospitalization and medical treatment using a variety of drugs that can fight the disease. These treatments often go through in vitro drug testing to expedite the process of producing the medication needed to treat the virus. People need to go through these treatments to prevent the worsening of their conditions.
Significance of Drug Treatments
These drug treatments are necessary to allow a person to recover from the disease. Aside from preventing the worsening of their condition, patients receive the treatment to hasten their recovery from the disease. Research has shown that the body may need at least two weeks to recover from the disease. But the recovery period depends on the severity of the illness and the underlying conditions of the patient.
These drug treatments have drawn the attention of many companies around the country since these treatments are part of the strategy of these companies in achieving normalcy. When the pandemic started, many of these companies had to make changes to prevent the virus from spreading by asking their employees to work from home.
Despite their work-from-home arrangements, some employees get infected when they go out to buy essentials for the home. With this, their productivity goes down, which affects the company. Therefore, many companies show interest in the widespread use of these treatments and the continuous release of the vaccines.
Therapies to Prevent Hospitalization
People experiencing mild to moderate symptoms of the disease can receive monoclonal antibody treatments so they can avoid hospitalization. These treatments include a combination of imdevimab and casirivimab. Another option is the combination of the etesevimab and bamlanivimab. These treatments can reduce the risk of these patients going to the hospital. But the treatments will still require visits to the clinic since a medical professional should give it to them intravenously.
While they are recovering at home, they should get a lot of rest. But they do not need to stay in bed all the time. They should also keep themselves well hydrated. Acetaminophen can take care of the fever, aches, and pains they are feeling. If they are taking any other medication, they should note all of them together with the doses.
Medications for Covid-19 Patients in the Hospital
Doctors can provide medication to Covid-19 patients who are experiencing severe cases of the disease. One of these medications is dexamethasone, an anti-inflammatory drug that is effective against severe and critical cases of Covid-19. These medicines are affordable and readily available. The National Institutes of Health (NIH) recommends its use on certain people infected by the disease.
People requiring ventilators and received dexamethasone have a bigger chance of surviving the disease than people receiving standard medical care. On the other hand, the medication did not show any positive effects for patients who did not require any supplementary oxygen while they were in the hospital.
Remdesivir is another drug used in treating Covid-19 patients. The anti-viral drug can help in modestly speeding up the recovery time of patients ages 12 years and above. Additionally, the patients should also weigh at least 88 pounds. Remdesivir was the first drug to receive approval from the US Food and Drug Administration (FDA) to allow its use in treating Covid-19 patients.
The use of blood thinners or anticoagulation drugs helps patients prevent blood clots among Covid-19 patients in the hospital. Doctors give these medications at low doses. But may give full doses to patients who already developed the blood clot or have an increased risk of developing it.
The doctors also need to balance the advantages and disadvantages since full doses of the blood thinner increase the risk of bleeding among these patients. Studies have also shown that full-dose blood thinners can also improve the outcome for these patients reduce the need for using a life-support system.
The end of the pandemic may already be in sight, but people should not be complacent since the virus is still present. With this, businesses should also continue with their efforts in safeguarding the health of their employees against the virus.